US · HLF · PACKAGED FOODS
Herbalife Nutrition Ltd. (HLF) intrinsic value and stock valuation
$15.53as of 2026-11-21 · Mkt cap 1.31B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Herbalife Nutrition Ltd. DCF and intrinsic value
InvestorsCraft values HLF with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from HLF’s statements →
Herbalife Nutrition Ltd. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.04B | $4.99B | $5.06B | $5.2B | $5.8B |
| Operating income | $441.5M | $385.9M | $356.4M | $545.2M | $734.1M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M |
| EPSd | $2.2M | $2.5M | $1.42M | $3.23M | $4.13M |
| Operating cash flow | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M |
| Capital expenditure | -$-80.4M | -$-122M | -$-135M | -$-156.4M | -$-151.4M |
| Free cash flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M |
| Total assets | $2.79B | $2.73B | $2.81B | $2.73B | $2.82B |
| Total debt | $2.34B | $2.47B | $2.77B | $2.92B | $3.01B |
| Net debt | $1.99B | $2.05B | $2.19B | $2.41B | $2.41B |
| Total equity | -$-509.4M | -$-801.1M | -$-1.06B | -$-1.27B | -$-1.39B |
| Cash and short-term investments | $353.1M | $415.3M | $575.2M | $508M | $601.5M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.04B | $4.99B | $5.06B | $5.2B | $5.8B |
| Cost of revenue | $1.23B | $1.1B | $1.19B | $1.17B | $1.24B |
| Gross profit | $3.81B | $3.89B | $3.87B | $4.03B | $4.56B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $3.45B | $3.51B | $3.53B | $1.81B | $2.01B |
| Other expenses | -$-79.3M | -$-5.5M | -$-10.2M | $1.68B | $1.82B |
| Operating expenses | $3.37B | $3.5B | $3.52B | $3.49B | $3.83B |
| Cost and expenses | $4.6B | $4.61B | $4.71B | $4.66B | $5.07B |
| Interest income | $8.5M | $12.3M | $11.5M | $6.1M | $4.4M |
| Interest expense | $214.4M | $218.3M | $165.9M | $139.3M | $153.1M |
| Depreciation and amortization | $121.2M | $121.4M | $113.3M | $115.4M | $107.6M |
| Ebitda | $610.7M | $509.1M | $482.2M | $679.5M | $821.5M |
| Operating income | $441.5M | $385.9M | $356.4M | $545.2M | $734.1M |
| Total other income/expenses, net | -$-166.4M | -$-216.5M | -$-153.4M | -$-120.4M | -$-173.3M |
| Income before tax | $275.1M | $169.4M | $203M | $424.8M | $560.8M |
| Income tax expense | $46.8M | -$-84.9M | $60.8M | $103.5M | $113.6M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M |
| Weighted average shares outstanding | $102.8M | $100.6M | $99M | $98.5M | $105.9M |
| Weighted average diluted shares outstanding | $103.6M | $101.6M | $100.2M | $99.5M | $108.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $353.1M | $415.3M | $575.2M | $508M | $601.5M |
| Net receivables | $91.9M | $68.9M | $81.2M | $70.6M | $66.9M |
| Inventory | $511.7M | $475.4M | $505.2M | $580.7M | $575.7M |
| Total current assets | $1.14B | $1.14B | $1.4B | $1.36B | $1.43B |
| Property, plant and equipment, net | $616M | $645.9M | $692.3M | $693.4M | $662.1M |
| Goodwill and intangible assets | $415.6M | $400M | $409.4M | $408.9M | $412.7M |
| Long-term investments | $24.5M | $18.5M | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $1.64B | $1.58B | $1.41B | $1.38B | $1.39B |
| Total assets | $2.79B | $2.73B | $2.81B | $2.73B | $2.82B |
| Accounts payable | $99.8M | $70M | $84M | $89.8M | $92M |
| Short-term debt | $56.4M | $323.2M | $349M | $66.9M | $72.2M |
| Deferred revenue | $0.00 | $75M | $64M | $53.9M | $63M |
| Total current liabilities | $1.01B | $1.23B | $1.28B | $976.6M | $1.08B |
| Long-term debt | $2.28B | $2.15B | $2.42B | $2.85B | $2.93B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $2.28B | $2.3B | $2.59B | $3.02B | $3.13B |
| Capital lease obligations | $157.3M | $210.4M | $207.1M | $229.8M | $245.1M |
| Total liabilities | $3.3B | $3.53B | $3.87B | $4B | $4.21B |
| Common stock | $100K | $100K | $100K | $100K | $100K |
| Retained earnings | -$-579.7M | -$-808M | -$-1.06B | -$-1.2B | -$-1.17B |
| Accumulated other comprehensive income (loss) | -$-251.5M | -$-271.4M | -$-232M | -$-250.2M | -$-211.8M |
| Total equity | -$-509.4M | -$-801.1M | -$-1.06B | -$-1.27B | -$-1.39B |
| Total investments | $24.5M | $18.5M | $0.00 | $0.00 | $0.00 |
| Total debt | $2.34B | $2.47B | $2.77B | $2.92B | $3.01B |
| Net debt | $1.99B | $2.05B | $2.19B | $2.41B | $2.41B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $227.8M | $254.3M | $142.2M | $321.3M | $447.2M |
| Depreciation and amortization | $121.2M | $121.4M | $113.3M | $115.4M | $107.6M |
| Stock-based compensation | $44.1M | $50M | $48M | $44.4M | $54.1M |
| Change in working capital | -$-35.5M | $32.5M | $47.7M | -$-123.1M | -$-218.3M |
| Accounts receivable | -$-19.7M | $5.9M | -$-9.1M | -$-9.1M | $9.6M |
| Inventory | -$-27.9M | -$-30.4M | $57.5M | -$-68.4M | -$-129.1M |
| Accounts payable | $24.1M | -$-14.6M | -$-7.4M | -$-1.1M | $6.9M |
| Net cash provided by operating activities | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M |
| Investments in property, plant and equipment | -$-80.4M | -$-122M | -$-135M | -$-156.4M | -$-151.4M |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-108.7M | -$-84.6M | -$-134.8M | -$-156.2M | -$-156.4M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-8.2M | -$-8.3M | -$-11M | -$-146.7M | -$-1.01B |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-295.5M | -$-335.3M | -$-148.3M | -$-264.7M | -$-728.6M |
| Net change in cash | -$-62.8M | -$-157.4M | $79.2M | -$-94.1M | -$-443.6M |
| Cash at end of period | $375.3M | $438.1M | $595.5M | $516.3M | $610.4M |
| Operating cash flow | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M |
| Capital expenditure | -$-80.4M | -$-122M | -$-135M | -$-156.4M | -$-151.4M |
| Free cash flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M |
Line items
Line items
Line items
About Herbalife Nutrition Ltd.
Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.
- CEO
- Stephan Paulo Gratziani
- Employees
- 8.5K
- Beta
- 0.87
Explore
Frequently asked questions
What is the intrinsic value of Herbalife Nutrition Ltd. (HLF)?
Herbalife Nutrition Ltd. (HLF) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is HLF undervalued?
HLF trades at a price of $15.53 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.